ISELIN, N.J., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Drug Topics ®, the leading multimedia resource for pharmacy professionals, today announced it added RPhAlly to its Strategic Alliance Partnership (SAP) ...
Through the print publication and a growing digital footprint, Drug Topics® provides a dynamic range of content across the pharmaceutical spectrum CRANBURY, N.J.--(BUSINESS WIRE)--Drug Topics®, a ...
This Research Topic is part of the Insights in Experimental Pharmacology and Drug Discovery series. You can explore the ...
Drug-drug interactions (DDIs) remain a critical challenge in both clinical practice and the drug discovery process, given their potential to produce unforeseen adverse effects and compromise patient ...
The global rise of antimicrobial resistance (AMR) among pathogenic microorganisms is widely recognised as one of the most pressing challenges in ...
Being able to accurately predict drug–target interactions (DTIs) and drug–target binding affinity (DTBA) is crucial in early drug development and during drug repurposing endeavors. Here, we look at ...
A drug used for 30 years to treat a variety of conditions may also improve cognition and halt neuron death in Alzheimer's. Two drugs already approved for cardiovascular conditions – pemafibrate and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results